Ironwood Pharmaceuticals, Inc. (IRWD)
3.52
-0.08
(-2.22%)
USD |
NASDAQ |
May 29, 13:20
Ironwood Pharmaceuticals EPS Diluted (Quarterly) : 0.2446 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 0.3861 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| Cytokinetics, Inc. | -1.671 |
| Geron Corp. | -0.0054 |
| Gilead Sciences, Inc. | 1.612 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 40.77M |
| Revenue (Quarterly) | 106.51M |
| Total Expenses (Quarterly) | 65.73M |
| Enterprise Value | 969.49M |
| Gross Profit Margin (Quarterly) | 99.58% |
| Profit Margin (Quarterly) | 38.28% |
| Earnings Yield | 16.97% |
| Operating Earnings Yield | 33.55% |
| Normalized Earnings Yield | 17.15 |